In 2026, both Medtronic and Abbott stocks have declined, altering their dividend yields and valuations. Medtronic now offers a higher dividend yield of 3.3% versus Abbott's 2.56%, making it more attractive for retirees needing income. Abbott, however, has a stronger long-term growth record and faster dividend increases, suitable for investors with a longer time horizon. Medtronic also trades at a lower valuation, providing similar upside potential with less risk. Overall, Medtronic is recommended for retirees prioritizing immediate income, while Abbott suits those focused on growth over 15+ years.
As of Oct 06, 2026 23:02 WIB, Medtronic (MDT) trades at USD 87.73 with a dividend yield of 3.27%, closer to its 52-week low of USD 73.75 than its high of USD 105.35, while Abbott (ABT) is priced higher at USD 99.29 with a lower yield of 2.52%, trading between its 52-week low of USD 82.57 and high of USD 134.27. MDT's market cap is $112.53B compared to ABT's $173.21B, and Pluang order activity shows more selling pressure on MDT (62% Sell) versus full buying interest in ABT (100% Buy). This contrast highlights MDT's appeal for income-focused investors relative to ABT's growth orientation.
